Diabetes & Primary Care’s series of interactive case studies is aimed at all healthcare professionals in primary and community care who would like to broaden their understanding of diabetes.
These two scenarios review the situations in which antiplatelet treatment may or may not be appropriate for cardiovascular protection in people with diabetes.
The format uses typical clinical scenarios as tools for learning. Information is provided in short sections, with most ending in a question to answer before moving on to the next section.
Working through the case studies will improve our knowledge and problem-solving skills in diabetes care by encouraging us to make evidence-based decisions in the context of individual cases.
Readers are invited to respond to the questions by typing in their answers. In this way, we are actively involved in the learning process, which is hopefully a much more effective way to learn.
By actively engaging with these case histories, readers will feel more confident and empowered to manage such presentations effectively in the future.
Rashmi, 51 years old, has type 2 diabetes of 4 years’ duration and no history of cardiovascular disease. Alongside her glucose-lowering medications and a statin, she is taking daily aspirin 75 mg.
What are your thoughts about her use of aspirin?
Kwame, 76 years old and with type 2 diabetes, had a transient ischaemic attack one year ago.
Would you recommend antiplatelet treatment for Kwame, and what type might you choose?
By working through this interactive case study, we will review how antiplatelet medications can reduce cardiovascular risk, and compare their benefits and risks when used for primary and secondary cardiovascular protection.
What can we do in practice to reduce the risk of this common yet underdiagnosed microvascular complication of diabetes?
12 Dec 2024